BNET Industries
Boston Scientific Corp. (BSX) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $8.3B
- Profit
- Dec 31 2007
- ($495.0M)
- Market Cap
- Oct 06 2008
- $15.5B
Latest News and Analysis
BellwetherReport.com Analyst Opinions on CY, BSX, LDK and PDX
BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...
CryoCath Announces Settlement of Pending Suits with CryoCor, Inc. and AMS Research Corp
www.cryocath.com Toronto Stock Exchange Symbol: CYT MONTREAL, Sept. 25 /PRNewswire-FirstCall/ -- CryoCathR Technologies Inc. (TSX: CYT.TO) announced today that it has resolved all outstanding patent suits among the company and Boston Scientific Corporation , its wholly-owned subsidiary, CryoCor, Inc., and CryoCor's co-plaintiff/co-defendant AMS Research Corporation. The companies...
Angiotech's corporate partner, Boston Scientific, announces FDA approval of TAXUS® Express™ Atom™ Stent System, first drug-eluting stent for small vessels
VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today reported that its corporate partner, Boston Scientific Corporation , has received U.S. Food and Drug Administration FDA approval to market its TAXUSR Express(2)TM AtomTM Paclitaxel-Eluting Coronary Stent System. The TAXUS...
Seven Summits Research Releases Comments on XOM, BSX, DAI, GME, and RHT
CHICAGO, Sept. 25 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0925Y (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven...
Boston Scientific Announces FDA Approval of TAXUS® Express2™ Atom™ Stent System, First Drug-Eluting Stent For Small Vessels
Company also announces FDA approval of TAXUSR Express2TM Stent System for treatment of in-stent restenosis NATICK, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has received approval from the U.S. Food and Drug Administration FDA to market its TAXUSR Express2TM AtomTM Paclitaxel-Eluting...
Zacks Analyst Interview Highlights: Abbott Labs, Amgen, Johnson & Johnson and Boston Scientific
CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Jason Napodano, who discusses Abbott Labs (NYSE: ABT), Amgen (Nasdaq: AMGN), Johnson & Johnson (NYSE: JNJ) and Boston Scientific (NYSE: BSX). Get the most recent insight from Zacks Equity Research with the free Profit...
Research and Markets: A Detailed Company Analysis of Boston Scientific Corporation: Providing a Medical Equipment Share Analysis & Valuable Company Data
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/0e4a75/boston_scientific) has announced the addition of the "Boston Scientific Corporation Medical Equipment Company Share Analysis" company profile to their offering. This report is an essential source for data, analysis and strategic insight into Boston Scientific Corporation. The report provides key information relating...
Boston Scientific to Participate in UBS Global Life Sciences Conference
NATICK, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22 - 25 in New York City. Jim Tobin, Boston Scientific Chief Executive Officer, will make a 30-minute presentation which will...
Boston Scientific's divested divisions have a new name
Boston Scientific's former fluid management and vascular access businesses announced a new name in early August. The new company, acquired in February by private-equity firm Avista Capital Partners, is called Navilyst Medical. "Navilyst Medical combines the best attributes of an established medical device company--market-leading technology, superior clinical data,...
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
Company to present data from landmark SYNTAX clinical trial NATICK, Mass., Aug. 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the schedule of the Company's major events and press announcements at the European Society of Cardiology Congress 2008, which runs from August 30 to September 3...
Navilyst Medical Announces Global Debut Today
Former Boston Scientific Business Units Combine to Lead Fluid Management and Vascular Access Markets MARLBOROUGH, Mass. -- Navilyst Medical, formerly Boston Scientific's Fluid Management and Vascular Access businesses, today announced its new company name following the February 2008 acquisition by Avista Capital Partners, a private equity firm focused...
Medtech Insight/Windhover Information's "Medical Device Investor Day" Symposium to Feature Presentations by 3M, B. Braun, BD, Boston Scientific, Covidien, Ethicon/J&J, Medtronic and Stryker, Among Others
October 22, 2008, Boston, MA IRVINE, Calif. -- Medtech Insight, a division of FDC/Windhover and Reed Elsevier and a leading provider of business information for the medical device industry, has announced that its first-of-its-kind "Medical Device Investor Day" symposium on October 22nd in Boston, MA, will feature illuminating...
DeviceSpace™ to Host Medical Device and Diagnostics Career Fair in Minneapolis
Medical Device and Diagnostics Event Expected to Attract a Record Number of Jobseekers MANASQUAN, N.J., July 29 /PRNewswire/ -- DeviceSpaceTM, the world's leading online medical device and diagnostics job board and career fair company, will host the DeviceSpace Career Fair in Minneapolis, Minnesota on Monday, September 8,...
Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer
LEXINGTON, Mass., July 24 /PRNewswire/ -- Tepha, Inc., a developer of medical devices derived from a new class of resorbable polymers, announced today that it has appointed John Hartnett to the new position of Executive Vice President and Chief Operating Officer. Mr. Hartnett joins Tepha following an eighteen...
Antisoma appoints Michael Lewis as a Non-Executive Director
9 July 2008 London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) todayannounces the appointment of Mr Michael Lewis as a Non-ExecutiveDirector with immediate effect. Mr Lewis is currently President for Europe, Middle East and Africaand was also Head of Global Marketing for the medical device companyGambro, with responsibility...
Research and Markets: A Performance Analysis of Johnson & Johnson in the Ethical Pharmaceutical Sector: Including a Six Year Sales Forecast and Competitor Profiling
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/a3817c/johnson_johnson) has announced the addition of the "Johnson & Johnson: PharmaVitae Profile" company profile to their offering. This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio...
Medtech Insight and FDC/Windhover Announce their Upcoming "Medical Device Investor Day" Symposium and "Investment In Innovation East" Conference
October 22-24, 2008, Boston, MA NEWPORT BEACH, Calif. -- Medtech Insight, a division of FDC/Windhover and Reed Elsevier and a leading provider of business information for the medical device industry, will host a first-of-its-kind "Medical Device Investor Day" symposium, followed immediately by their "Investment In...
Joe Hallow Named to the Board of Directors of BridgePoint Medical, LLC
LEXINGTON, Ky., July 8 /PRNewswire/ -- BridgePoint Medical, LLC, an independently owned prosthetic and orthotic company, today announced that Joseph F. Hallow, III has been elected to serve on its Board of Directors. Mr. Hallow currently serves as president of Bissell Hotels in Charlotte, North Carolina....
Syndicated Radio Host Mel Robbins to Broadcast Advice and Interview Show Live from Borders® in Downtown Crossing, Boston
First Guest in Robbins' New Borders Radio Booth is Bestselling Author Dennis Lehane ANN ARBOR, Mich., July 8 /PRNewswire-FirstCall/ -- BordersR and Advice for Living Inc. are excited to announce that "Make It Happen" -- a nationally syndicated radio program hosted by respected life...
Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/9cbe1a/australia_cardiova) has announced the addition of the "Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering. Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 Summary: This report is...
- Next »
- page 1 of 1
- « Previous
- Incorporated: 1979
- CEO: Mr. James R. Tobin
Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a variety of interventional medical specialties including interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation. Co.'s products are offered for sale mainly by three business groups: Cardiovascular, which includes its interventional cardiology, cardiac rhythm management and cardiovascular divisions; Endosurgery, which includes its oncology, endoscopy and urology/gynecology divisions; and Neuromodulation, which includes its auditory and pain management divisions.
Key Competitors
Boston Scientific Corp. Company Info
Board of Directors
Mr. Peter M. Nicholas
Chairman
Mr. James R. Tobin
Mr. John E. Abele
Mr. Joel L. Fleishman
Dr. Kristina M. Johnson Ph.D.
Dr. Ernest Mario Ph.D.
Dr. Uwe E. Reinhardt
Ms. Ursula M. Burns
Ms. Nancy-Ann DeParle
Mr. J. Raymond Elliott
Dr. Marye Anne Fox Ph.D.
Mr. Ray J. Groves
Mr. N. J. Nicholas Jr.
Mr. John E. Pepper Jr.
Senator Warren B. Rudman
Contact Information
One Boston Scientific Place
Natick, MA
508 650-8000
NAICS Code
Surgical and Medical Instrument Manufacturing: 339112
